New Therapeutic Strategies for Brain Edema and Cell Injury

<p>1. 5-hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology<br>Aruna Sharma, Rudy J. Castellani, Mark A. Smith, Dafin F. Muresanu, Prasanta Kumar Dey and Hari S. Sharma<br>2. Anaesthetics influence concussive head injury induced blood-brain barrier breakdown, brain edema formation, cerebral blood flow, serotonin levels, brain pathology, and functional outcome<br>Hari S. Sharma, Dafin F. Muresanu, Ala Nozari, Rudy J. Castellani, Prasanta K. Dey, Lars Wiklund and Aruna Sharma<br>3. Exacerbation of blood-brain barrier breakdown, edema formation, nitric oxide synthase upregulation, and brain pathology after heat stroke in diabetic and hypertensive rats: Potential neuroprotection with cerebrolysin treatment<br>Dafin F. Muresanu, Aruna Sharma, Ranjana Patnaik, Preeti K. Menon, Herbert Mössler and Hari Shanker Sharma<br>4. Neuroprotective effects of a potent bradykinin B2 receptor antagonist HOE-140 on microvascular permeability, blood flow disturbances, edema formation, cell injury, and nitric oxide synthase upregulation following trauma to the spinal cord<br>Hari Shanker Sharma, Lianyuan Feng, Dafin Fior Muresanu, Rudy J. Castellani and Aruna Sharma<br>5. Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation<br>Seaab Sahib, Feng Niu, Aruna Sharma, Lianyuan Feng, Z. Ryan Tian, Dafin F. Muresanu, Ala Nozari and Hari Shanker Sharma<br>6. Leakage of the blood-brain barrier followed by vasogenic edema as the ultimate cause of death induced by acute methamphetamine overdose<br>Eugene A. Kiyatkin and Hari S. Sharma<br>7. Neuroprotective effects of 5-HT3 receptor antagonist ondansetron on morphine withdrawal induced brain edema formation, blood-brain barrier dysfunction, neuronal injuries, glial activation, and heat shock protein upregulation in the brain<br>Aruna Sharma, Ranjana Patnaik and Hari Shanker Sharma<br>8. Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders<br>Mario Antonazzo, María Botta, Harkaitz Bengoetxea, José Ángel Ruiz-Ortega and Teresa Morera-Herreras<br>9. Dysfunction of serotonergic neurons in Parkinson’s disease and dyskinesia<br>Vegas-Suarez Sergio, Paredes-Rodriguez Elena, Aristieta Asier, Lafuente Jose V., Miguelez Cristina, Ugedo Luisa<br>10. New therapeutic approaches to target alpha-synuclein in Parkinson’s disease: The role of immunotherapy<br>Fernández-Valle T., Gabilondo I. and Gómez-Esteban J.C.</p>